TY - JOUR AU - Pachman, D. R. AU - Qin, R. AU - Seisler, D. K. AU - Smith, E. M. AU - Beutler, A. S. AU - Ta, L. E. PY - 2015 DA - 2015// TI - Clinical course of Oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance) JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.8533 DO - 10.1200/JCO.2014.58.8533 ID - Pachman2015 ER - TY - JOUR AU - Kidwell, K. M. AU - Yothers, G. AU - Ganz, P. A. AU - Land, S. R. AU - Ko, C. Y. AU - Cecchini, R. S. PY - 2012 DA - 2012// TI - Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and bowel project trials C-07 and LTS-01 JO - Cancer. VL - 118 UR - https://doi.org/10.1002/cncr.27593 DO - 10.1002/cncr.27593 ID - Kidwell2012 ER - TY - JOUR AU - Fan, H. C. AU - Blumenfeld, Y. J. AU - Chitkara, U. AU - Hudgins, L. AU - Quake, S. R. PY - 2010 DA - 2010// TI - Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing JO - Clin Chem VL - 56 UR - https://doi.org/10.1373/clinchem.2010.144188 DO - 10.1373/clinchem.2010.144188 ID - Fan2010 ER - TY - JOUR AU - Diehl, F. AU - Schmidt, K. AU - Choti, M. A. AU - Romans, K. AU - Goodman, S. AU - Li, M. PY - 2008 DA - 2008// TI - Circulating mutant DNA to assess tumor dynamics JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm.1789 DO - 10.1038/nm.1789 ID - Diehl2008 ER - TY - JOUR AU - Tie, J. AU - Wang, Y. AU - Tomasetti, C. AU - Li, L. AU - Springer, S. AU - Kinde, I. PY - 2016 DA - 2016// TI - Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aaf6219 DO - 10.1126/scitranslmed.aaf6219 ID - Tie2016 ER - TY - JOUR AU - Reinert, T. AU - Henriksen, T. V. AU - Christensen, E. AU - Sharma, S. AU - Salari, R. AU - Sethi, H. PY - 2019 DA - 2019// TI - Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer JO - JAMA Oncol VL - 5 UR - https://doi.org/10.1001/jamaoncol.2019.0528 DO - 10.1001/jamaoncol.2019.0528 ID - Reinert2019 ER - TY - JOUR AU - Lin, P. C. AU - Yeh, Y. M. AU - Wu, P. Y. AU - Hsu, K. F. AU - Chang, J. Y. AU - Shen, M. R. PY - 2019 DA - 2019// TI - Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-40571-0 DO - 10.1038/s41598-019-40571-0 ID - Lin2019 ER - TY - STD TI - Fleming CA, O'Leary DP, Wang J, Redmond HP. Association of Observed Perioperative Cell-Free DNA Dynamics With Early Recurrence in Patients With Colon Cancer. JAMA Surg. 2020;155(2):168–70. ID - ref8 ER - TY - JOUR AU - McGranahan, N. AU - Swanton, C. PY - 2015 DA - 2015// TI - Biological and therapeutic impact of intratumor heterogeneity in cancer evolution JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2014.12.001 DO - 10.1016/j.ccell.2014.12.001 ID - McGranahan2015 ER - TY - JOUR AU - Bronkhorst, A. J. AU - Ungerer, V. AU - Holdenrieder, S. PY - 2019 DA - 2019// TI - The emerging role of cell-free DNA as a molecular marker for cancer management JO - Biomol Detect Quantif VL - 17 UR - https://doi.org/10.1016/j.bdq.2019.100087 DO - 10.1016/j.bdq.2019.100087 ID - Bronkhorst2019 ER -